Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement



Status:Active, not recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:12/7/2016
Start Date:November 2015
End Date:January 2017

Use our guide to learn which trials are right for you!

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement: the ACIST-FFR Study

This study will assess the differences between Fractional Flow Reserve (FFR) measurements
made by the Navvus catheter and a commercially available pressure guidewire in up to 240
subjects where FFR is clinically indicated. All subjects will receive diagnostic treatment
according to clinical indications and center standard practice.

The ACIST-FFR study is a prospective, open label, observational, multi-center study designed
to assess the differences, if any, between FFR measured by the Navvus catheter and a
commercially available 0.014-inch pressure guidewire (St. Jude Medical, Volcano, hereafter
referred to as the PW) in subjects with coronary artery disease (CAD) undergoing coronary
angiography. This will be accomplished by comparing the FFR measurement obtained with the
ACIST Medical Systems RXi System and Navvus catheter with the FFR measurement obtained by
using a PW within the same subject across the same target lesion at the same time.

General Inclusion Criteria:

- Subject is 18 years of age or older

- Subject has a clinical indication for coronary angiography

- Subject or subject's legal representative has the ability to understand and provide
signed consent for participating in the study

Angiographic Inclusion Criteria:

- Vessel has a TIMI flow = 3

- Subject has de novo lesion which physician has determined has a clinical indication
for FFR measurement

- RVD of the target lesion is assessed by the operator to be ≥2.25 mm.

General Exclusion Criteria:

- Subjects with acute ST-elevation or non-ST-elevation myocardial infarction as the
indication for coronary angiography

- NYHA Class 4 severe heart failure

Angiographic Exclusion Criteria:

- Target vessel has angiographically visible or suspected thrombus.

- Target lesion is within a bypass graft.

- Angiographic evidence of a dissection prior to initiation of PW measurements.

- Target vessel contains excessive tortuosity or calcification.
We found this trial at
12
sites
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Chicago, Illinois 60637
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cleveland, Ohio 44195
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
La Jolla, California 92037
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Long Beach, California 90822
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Stanford, California 94305
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials
West Des Moines, Iowa 50266
?
mi
from
West Des Moines, IA
Click here to add this to my saved trials